These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8380185)

  • 1. Sympathetic alterations after sodium restriction and short-term captopril administration.
    Mills PJ; Dimsdale JE; Ziegler MG; Hauger RL; Nelesen RA; Brown MR
    J Am Coll Cardiol; 1993 Jan; 21(1):177-81. PubMed ID: 8380185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenergic receptor sensitivity during sodium restriction and converting enzyme inhibition.
    Mills P; Dimsdale J; Ziegler M; Brown M
    Clin Exp Hypertens A; 1990; 12(2):179-90. PubMed ID: 2161301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased angiotensin II response but unaltered cardiovascular pressor response to infused norepinephrine after sodium restriction and converting enzyme inhibition.
    Mills PJ; Dimsdale JE; Ziegler MG; Nelesen RA; Brown MR
    Clin Pharmacol Ther; 1993 Apr; 53(4):450-6. PubMed ID: 8477561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cardiac beta-adrenergic receptors by captopril. Implications for congestive heart failure.
    Maisel AS; Phillips C; Michel MC; Ziegler MG; Carter SM
    Circulation; 1989 Sep; 80(3):669-75. PubMed ID: 2548769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J; Cody RJ; Laragh JH
    Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin converting enzyme inhibition and sympathetic activity in healthy subjects.
    Lang CC; Stein CM; He HB; Wood AJ
    Clin Pharmacol Ther; 1996 Jun; 59(6):668-74. PubMed ID: 8681492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Captopril does not blunt the sympathoadrenal response to cigarette smoking in normotensive humans.
    Ottesen MM; Worck R; Ibsen H
    Blood Press; 1997 Jan; 6(1):29-34. PubMed ID: 9116923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in plasma norepinephrine concentration and thrombocyte alpha 2-adrenoceptor density during long-term antihypertensive therapy with nitrendipine and captopril.
    Müller R; Steffen HM; Weller P; Kugel C; Freiheit T; Krone W
    J Cardiovasc Pharmacol; 1994 Sep; 24(3):429-33. PubMed ID: 7528299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of sympathetic nervous system activity in the blood pressure response to long-term captopril therapy in severely hypertensive patients.
    Weinberger MH
    Am J Cardiol; 1982 Apr; 49(6):1542-3. PubMed ID: 7041594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system.
    Zanchi A; Schaad NC; Osterheld MC; Grouzmann E; Nussberger J; Brunner HR; Waeber B
    Am J Physiol; 1995 Jun; 268(6 Pt 2):H2267-73. PubMed ID: 7541960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibition, catecholamines and hemodynamics in essential hypertension.
    Muiesan G; Alicandri CL; Agabiti-Rosei E; Fariello R; Beschi M; Boni E; Castellano M; Moniti E; Muiesan L; Romanelli G; Zanielli A
    Am J Cardiol; 1982 Apr; 49(6):1420-4. PubMed ID: 6280474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition.
    Kiowski W; Linder L; Kleinbloesem C; van Brummelen P; Bühler FR
    Circulation; 1992 Jan; 85(1):1-8. PubMed ID: 1728438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Captopril modifies the hemodynamic and neuroendocrine responses to sodium nitroprusside in hypertensive patients.
    Clementi WA; Durst NL; McNay JL; Keeton TK
    Hypertension; 1986 Mar; 8(3):229-37. PubMed ID: 3512428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central and peripheral vasopressin interact differently with sympathetic nervous system and renin-angiotensin system in renal hypertensive rabbits.
    Kumagai H; Suzuki H; Ichikawa M; Matsumura Y; Jimbo M; Ryuzaki M; Saruta T
    Circ Res; 1993 Jun; 72(6):1255-65. PubMed ID: 8495554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurohumoral response to sublingual captopril and nifedipine in hypertensive emergencies and during the cold test. Contribution to the study of the interaction between the sympathetic and renin-angiotensin systems and atrial natriuretic factor].
    Polónia JJ; Pedro-Nunes J; da Silva MV; Esteves AP; Cunha ME; Brandão FA; Gomes MC
    Rev Port Cardiol; 1988; 7(4):389-98. PubMed ID: 2978843
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic effects of direct vasodilation (pinacidil), alpha-adrenergic blockade (prazosin) and angiotensin-converting enzyme inhibition (captopril) in systemic hypertension.
    Izzo JL; Licht MR; Smith RJ; Larrabee PS; Radke KJ; Kallay MC
    Am J Cardiol; 1987 Aug; 60(4):303-8. PubMed ID: 2887102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of chronic captopril therapy on adrenergic receptors, plasma noradrenaline and the vascular responses to infused noradrenaline.
    Kondowe GB; Copeland S; Passmore AP; Leahey WJ; Johnston GD
    Eur J Clin Pharmacol; 1987; 32(3):229-35. PubMed ID: 3297732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympathomoderating influence of benazepril in essential hypertension.
    Giannattasio C; Cattaneo BM; Omboni S; Seravalle G; Bolla G; Turolo L; Morganti A; Grassi G; Zanchetti A; Mancia G
    J Hypertens; 1992 Apr; 10(4):373-8. PubMed ID: 1316404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined sympathetic suppression and angiotensin-converting enzyme inhibition in congestive heart failure.
    Manolis AJ; Olympios C; Sifaki M; Handanis S; Cokkinos D; Bresnahan M; Gavras I; Gavras H
    Hypertension; 1997 Jan; 29(1 Pt 2):525-30. PubMed ID: 9039154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.